Ibnsina Pharma

CASE:ISPH Stock Report

Market Cap: ج.م5.7b

Ibnsina Pharma Future Growth

Future criteria checks 5/6

Ibnsina Pharma is forecast to grow earnings and revenue by 43.2% and 14.9% per annum respectively. EPS is expected to grow by 41.3% per annum. Return on equity is forecast to be 32.5% in 3 years.

Key information

43.2%

Earnings growth rate

41.3%

EPS growth rate

Healthcare earnings growth27.8%
Revenue growth rate14.9%
Future return on equity32.5%
Analyst coverage

Low

Last updated16 Oct 2024

Recent future growth updates

Recent updates

Earnings and Revenue Growth Forecasts

CASE:ISPH - Analysts future estimates and past financials data (EGP Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202668,3801,0409581,6691
12/31/202560,9035122668961
12/31/202452,435515-2051721
9/30/202448,546361516710N/A
6/30/202442,066246-25347N/A
3/31/202437,680195-74272N/A
12/31/202333,949173-236126N/A
9/30/202330,258184-40204N/A
6/30/202326,7001747901,509N/A
3/31/202323,775144159672N/A
12/31/202222,264136-463362N/A
9/30/202221,792180-1,332-381N/A
6/30/202221,870269-1,844-1,537N/A
3/31/202222,309293-1,300-847N/A
12/31/202121,733286-499-340N/A
9/30/202120,729218-340-172N/A
6/30/202119,929197147412N/A
3/31/202118,992184-113166N/A
12/31/202018,67918421252N/A
9/30/202018,373233407692N/A
6/30/202017,928258166443N/A
3/31/202017,317276-24473N/A
12/31/201916,600269-384-25N/A
9/30/201915,820287-821-451N/A
6/30/201914,919264-1,071-653N/A
3/31/201914,169254-653-258N/A
12/31/201813,324242-747-303N/A
9/30/201812,305181-28394N/A
6/30/201811,462177N/A410N/A
3/31/201810,561174N/A239N/A
12/31/20179,586162N/A436N/A
9/30/20178,917157N/A463N/A
12/31/20167,206102N/A216N/A
12/31/20155,32657N/A32N/A
12/31/20144,19738N/A46N/A
12/31/20133,27435N/A-35N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: ISPH's forecast earnings growth (43.2% per year) is above the savings rate (14.7%).

Earnings vs Market: ISPH's earnings (43.2% per year) are forecast to grow faster than the EG market (14.8% per year).

High Growth Earnings: ISPH's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: ISPH's revenue (14.9% per year) is forecast to grow faster than the EG market (13.9% per year).

High Growth Revenue: ISPH's revenue (14.9% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: ISPH's Return on Equity is forecast to be high in 3 years time (32.5%)

Discover growth companies

7D

1Y

7D

1Y

7D

1Y